CRINETICS PHARMACEUTICALS IN

Ticker: CRNX CUSIP: 22663K107 Class: EQTY

MAPLELANE CAPITAL, LLC's Holding History (CIK: 0001512173)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 160,000 Value ($000) $8,176 Avg Close $51.57 Range $43.71 - $55.78
Q2 2024
Shares 160,000 Value ($000) $7,166 Avg Close $46.18 Range $41.01 - $53.70